Bayern Kapital

Founded in 1995, Bayern Kapital is a venture capital firm based in Landshut, Germany. It specializes in growth capital investments, focusing on high-tech companies in sectors such as biotechnology, IT, and environmental technology. The firm primarily invests in small and medium-sized companies located exclusively in Bavaria, with typical investment amounts ranging from €0.25 million to €9 million.

Matthias Buchinger

Investment Manager

Regina Graßl

Investor

Andreas Huber

Investor

Roman Huber

Managing Director

Wolfgang Härtl

Investor

Simon Kreitmair

Investor

Bernhard Köhler

Investment Director and Authorized Signatory

Johanna Liebner

Investor

Brigitte Linseis

Senior Investment Manager

Thomas Manitta

Investor

Mathias Matusek

Analyst

Markus Porsch

Investment Analyst

Martin Redl

Investor

Georg Ried

Managing Director

Franz Salzer

Investor

Bernd Schafberger

Managing Director

Benjamin Schwiewagner

Investment Director

Nathalie Weitemeyer

Investor

Franz Wocheslander

Investor

Past deals in Nanotechnology

CPTx

Venture Round in 2024
CPTx is a biotechnology company specializing in the development of single-stranded DNA products. Its core technology involves using programmable DNA nanofabrication to encapsulate and neutralize viruses, offering a novel approach to treating infectious diseases. By precisely positioning and presenting various drug molecules, CPTx enables the creation of innovative medical treatments, addressing significant healthcare challenges.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.